Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_32391 | 75 | 1.56 | Mlig455_017179, Mlig455_048147 | Neo: - Age: - |
SDCBP2 | Mlig455_017179 {REF} {Length: 3606} {Pfam: PDZ domain [PF00595.26, score=88.1]; PDZ domain [PF17820.3, score=72.4]; PDZ domain [PF13180.8, score=47.6]; Immunoglobulin domain [PF13927.8, score=44.1]; Immunoglobulin domain [PF00047.27, score=37.4]; Immunoglobulin V-set domain [PF07686.19, score=35.7]; Immunoglobulin I-set domain [PF07679.18, score=25.6]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=59.3, Expect=2e-09]; ENSG00000006611, USH1C, USH1 protein network component harmonin, [Score=56.6, Expect=2e-07]} {Mouse: ENSMUSG00000038298, Pdzk1, PDZ domain containing 1, [Score=60.1, Expect=8e-09]; ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=60.1, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=59.3, Expect=5e-09]} {Dmel: FBgn0029835, CG5921, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=63.2, Expect=7e-10]} {Smed: dd_Smed_v6_21860_0_1, dd_Smed_v6_21860_0_1, [RH, Score=146, Expect=2e-38]} {RNA1509_22767} {RNA1310_28491} {RNA815_60114} Mlig455_048147 {REF} {Length: 2119} {Pfam: Immunoglobulin domain [PF13927.8, score=47.4]; Immunoglobulin domain [PF00047.27, score=41.5]; Immunoglobulin V-set domain [PF07686.19, score=40.0]; Immunoglobulin I-set domain [PF07679.18, score=29.2]; Immunoglobulin domain [PF13895.8, score=25.4]} {RNA1509_22767} {RNA1310_34847} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 6.518 | 1.674 | 0.01407 | 0.33370 | |
RegionR2 | 0.141 | 1.674 | 0.89423 | 1.00000 | |
RegionR3 | -2.032 | 1.674 | 0.02238 | 0.25374 | |
RegionR4 | 1.413 | 1.674 | 0.24911 | 0.54829 | |
RegionR5 | -3.554 | 1.674 | 0.00014 | 0.00222 | |
RegionR6 | -1.7 | 1.674 | 0.05590 | 0.44364 | |
RegionR7 | -1.42 | 1.674 | 0.28944 | 0.92284 | |
RegionR8 | 0.634 | 1.674 | 0.75821 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -10.098 | 1.674 | 0.02361 | 0.59347 | |
RegenerationR2 | -1.388 | 1.674 | 0.03929 | 0.32756 | |
RegenerationR3 | -1.625 | 1.674 | 0.12245 | 0.54248 | |
RegenerationR4 | -2.988 | 1.674 | 0.01416 | 0.18591 | |
RegenerationR5 | 1.18 | 1.674 | 0.33676 | 0.75535 | |
RegenerationR6 | -1.162 | 1.674 | 0.24489 | 0.59274 | |
RegenerationBL | -5.286 | 1.674 | 0.03320 | 0.20441 | |
RegenerationTP | -6.382 | 1.674 | 0.00726 | 0.14344 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_32391 | 75 | 1.56 | Mlig455_017179, Mlig455_048147 | Neo: - Age: - |
SDCBP2 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_017179 {REF} {Length: 3606} {Pfam: PDZ domain [PF00595.26, score=88.1]; PDZ domain [PF17820.3, score=72.4]; PDZ domain [PF13180.8, score=47.6]; Immunoglobulin domain [PF13927.8, score=44.1]; Immunoglobulin domain [PF00047.27, score=37.4]; Immunoglobulin V-set domain [PF07686.19, score=35.7]; Immunoglobulin I-set domain [PF07679.18, score=25.6]} {Human: ENSG00000125775, SDCBP2, syndecan binding protein 2, [Score=59.3, Expect=2e-09]; ENSG00000006611, USH1C, USH1 protein network component harmonin, [Score=56.6, Expect=2e-07]} {Mouse: ENSMUSG00000038298, Pdzk1, PDZ domain containing 1, [Score=60.1, Expect=8e-09]; ENSMUSG00000030838, Ush1c, USH1 protein network component harmonin, [Score=60.1, Expect=1e-08]; ENSMUSG00000027456, Sdcbp2, syndecan binding protein (syntenin) 2, [Score=59.3, Expect=5e-09]} {Dmel: FBgn0029835, CG5921, [Score=55.1, Expect=2e-07]} {Celegans: WBGene00003404, mpz-1, Multiple PDZ domain protein, [Score=63.2, Expect=7e-10]} {Smed: dd_Smed_v6_21860_0_1, dd_Smed_v6_21860_0_1, [RH, Score=146, Expect=2e-38]} {RNA1509_22767} {RNA1310_28491} {RNA815_60114} Mlig455_048147 {REF} {Length: 2119} {Pfam: Immunoglobulin domain [PF13927.8, score=47.4]; Immunoglobulin domain [PF00047.27, score=41.5]; Immunoglobulin V-set domain [PF07686.19, score=40.0]; Immunoglobulin I-set domain [PF07679.18, score=29.2]; Immunoglobulin domain [PF13895.8, score=25.4]} {RNA1509_22767} {RNA1310_34847} |
2. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
3.477 | 0.757 | - | 0.898 | 0.855 | 0.967 | - | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
3. | MligTC455_39078 | 130 | 2.7 | Mlig455_060090 | Neo: - Age: - |
3.267 | 0.861 | 0.704 | 0.739 | - | 0.963 | - | Mlig455_060090 {REF} {Length: 493} {NoTransDecoderORF} {RNA1509_45542} {RNA1310_46086} {RNA815_33321.1} | |
4. | MligTC455_40340 | 201 | 4.19 | Mlig455_021026, Mlig455_021062 | Neo: - Age: - |
2.768 | 0.868 | - | 0.970 | - | 0.930 | - | Mlig455_021026 {REF} {Length: 1609} {RNA1310_21018} {RNA815_22069} Mlig455_021062 {REF} {Length: 1582} {RNA1310_21018} {RNA815_22069} |
|
5. | MligTC455_40226 | 43 | 0.89 | Mlig455_010646, Mlig455_010651 | Neo: - Age: - |
GRIK2 | 2.739 | - | - | 0.952 | 0.945 | 0.842 | - | Mlig455_010646 {REF} {Length: 1094} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1310_59687} {RNA815_48326} Mlig455_010651 {REF} {Length: 3614} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.3]; LIM domain [PF00412.24, score=31.8]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=137, Expect=3e-32]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=135, Expect=8e-32]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=133, Expect=6e-31]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=136, Expect=4e-32]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=135, Expect=7e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=134, Expect=2e-31]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=278, Expect=1e-79]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=254, Expect=2e-74]} {Smed: dd_Smed_v6_5330_0_1, dd_Smed_v6_5330_0_1, [Score=196, Expect=5e-51]} {RNA1509_35609} {RNA1310_6947.1} {RNA815_20684} |
6. | MligTC455_13434 | 15 | 0.3 | Mlig455_025922 | Neo: - Age: - |
2.725 | - | 0.803 | 0.943 | - | 0.979 | - | Mlig455_025922 {REF} {Length: 1467} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=36.3]} {RNA1310_51631} {RNA815_34338} | |
7. | MligTC455_13563 | 29 | 0.6 | Mlig455_057359, Mlig455_059570 | Neo: - Age: - |
2.692 | - | 0.837 | 0.950 | - | 0.905 | - | Mlig455_057359 {REF} {Length: 700} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} Mlig455_059570 {REF} {Length: 395} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} |
|
8. | MligTC455_21583 | 64 | 1.33 | Mlig455_001407, Mlig455_064265 | Neo: - Age: - |
PDE8A | 2.679 | 0.792 | 0.931 | - | - | 0.956 | - | Mlig455_001407 {REF} {Length: 4083} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=278.7]; PAS domain [PF13426.9, score=22.9]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=589, Expect=0.0]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=568, Expect=0.0]; ENSG00000284762, AC022414.1, phosphodiesterase 8B, [Score=565, Expect=0.0]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=579, Expect=0.0]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=569, Expect=0.0]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=357, Expect=4e-110]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=312, Expect=6e-94]} {Smed: dd_Smed_v6_10593_0_1, dd_Smed_v6_10593_0_1, [Score=410, Expect=2e-130]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} Mlig455_064265 {REF} {Length: 3769} {TRANSSPLICED} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=279.8]} {Human: ENSG00000073417, PDE8A, phosphodiesterase 8A, [Score=519, Expect=2e-172]; ENSG00000113231, PDE8B, phosphodiesterase 8B, [Score=495, Expect=4e-162]} {Mouse: ENSMUSG00000025584, Pde8a, phosphodiesterase 8A, [Score=499, Expect=1e-164]; ENSMUSG00000021684, Pde8b, phosphodiesterase 8B, [Score=496, Expect=8e-164]} {Dmel: FBgn0266377, Pde8, Phosphodiesterase 8, [Score=361, Expect=5e-112]} {Celegans: WBGene00022389, pde-6, Probable 3',5'-cyclic phosphodiesterase pde-6, [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_10593_0_2, dd_Smed_v6_10593_0_2, [Score=404, Expect=1e-128]} {RNA1509_38664} {RNA1310_9544} {RNA815_9009} |
9. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.674 | 0.783 | - | 0.956 | - | 0.935 | - | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
10. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.624 | - | 0.790 | 0.952 | - | 0.882 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
11. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.617 | - | 0.791 | 0.852 | - | 0.974 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
12. | MligTC455_49094 | 59 | 1.22 | Mlig455_065396 | Neo: - Age: - |
RERGL | 2.612 | - | 0.800 | 0.955 | - | 0.857 | - | Mlig455_065396 {REF} {Length: 1449} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=61.9]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=25.4]} {Human: ENSG00000111404, RERGL, RERG like, [Score=80.5, Expect=7e-18]; ENSG00000134533, RERG, RAS like estrogen regulated growth inhibitor, [Score=80.1, Expect=7e-18]} {Mouse: ENSMUSG00000092164, Rergl, RERG/RAS-like, [Score=84.7, Expect=1e-19]} {Dmel: FBgn0035711, CG8519, [Score=69.3, Expect=4e-14]} {Celegans: WBGene00004309, rap-3, RAP homolog (Vertebrate Rap GTPase family), [Score=59.3, Expect=1e-10]} {Smed: dd_Smed_v6_7273_0_1, dd_Smed_v6_7273_0_1, [Score=80.1, Expect=3e-18]} {RNA1509_41924} {RNA1310_34154} {RNA815_43516} |
13. | MligTC455_42580 | 98 | 2.04 | Mlig455_014929, Mlig455_045199 | Neo: - Age: - |
NKX2-2 | 2.608 | 0.710 | - | 0.958 | - | 0.940 | - | Mlig455_014929 {REF} {Length: 1652} {Pfam: Homeodomain [PF00046.31, score=70.3]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=138, Expect=2e-37]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=1e-37]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=4e-35]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=107, Expect=6e-26]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=1e-29]} {RNA1310_42496} {RNA815_52707} Mlig455_045199 {REF} {Length: 1211} {Pfam: Homeodomain [PF00046.31, score=71.0]} {Human: ENSG00000125820, NKX2-2, NK2 homeobox 2, [RH, Score=139, Expect=6e-39]} {Mouse: ENSMUSG00000027434, Nkx2-2, NK2 homeobox 2, [RH, Score=139, Expect=3e-39]} {Dmel: FBgn0261930, vnd, ventral nervous system defective, [RH, Score=138, Expect=1e-36]} {Celegans: WBGene00000445, ceh-22, Homeobox protein ceh-22, [RH, Score=108, Expect=2e-27]} {Smed: dd_Smed_v6_2716_0_1, dd_Smed_v6_2716_0_1, [RH, Score=120, Expect=7e-31]} {RNA1310_42496} {RNA815_52707} |
14. | MligTC455_50533 | 66 | 1.38 | Mlig455_064328 | Neo: - Age: - |
2.602 | 0.834 | - | 0.950 | - | 0.818 | - | Mlig455_064328 {REF} {Length: 838} {RNA1310_88153} {RNA815_57541} | |
15. | MligTC455_26652 | 30 | 0.63 | Mlig455_036452 | Neo: - Age: - |
NR2E1 | 2.589 | 0.718 | - | 0.986 | - | 0.885 | - | Mlig455_036452 {REF} {Length: 2848} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=99.9]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=55.3]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [Score=139, Expect=2e-35]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=139, Expect=1e-35]} {Dmel: FBgn0015381, dsf, dissatisfaction, [Score=129, Expect=6e-31]} {Celegans: WBGene00021417, nhr-236, Nuclear Hormone Receptor family, [RH, Score=135, Expect=1e-35]} {Smed: dd_Smed_v6_25420_0_1, dd_Smed_v6_25420_0_1, [RH, Score=182, Expect=3e-50]} {RNA1310_57853} {RNA815_57699} |
16. | MligTC455_32312 | 65 | 1.36 | Mlig455_026936, Mlig455_027086 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.552/0.00000 |
2.587 | 0.779 | - | 0.954 | 0.854 | - | - | Mlig455_026936 {REF} {Length: 1813} {Pfam: PAN domain [PF00024.28, score=22.0]} {RNA1310_30037.2} {RNA815_37290} Mlig455_027086 {REF} {Length: 7697} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1509_4722} {RNA1310_655.1} {RNA815_786} |
|
17. | MligTC455_31163 | 72 | 1.51 | Mlig455_045625 | Neo: - Age: Up-Down-Down |
2.571 | 0.748 | - | 0.981 | - | 0.842 | - | Mlig455_045625 {REF} {Length: 1957} {RNA1509_21720} {RNA1310_14760, RNA1509_21720} {RNA1509_21720, RNA815_24583} | |
18. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 2.551 | - | 0.736 | 0.843 | - | 0.972 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |
19. | MligTC455_43382 | 30 | 0.63 | Mlig455_035066 | Neo: - Age: Up-Up-Down |
KIAA0513 | 2.543 | 0.751 | - | 0.808 | - | 0.984 | - | Mlig455_035066 {REF} {Length: 5084} {Pfam: Myotubularin protein [PF12335.10, score=30.0]} {Human: ENSG00000135709, KIAA0513, KIAA0513, [RH, Score=107, Expect=7e-25]} {Mouse: ENSMUSG00000031824, 6430548M08Rik, RIKEN cDNA 6430548M08 gene, [RH, Score=107, Expect=5e-25]} {Dmel: FBgn0031858, CG17378, [RH, Score=108, Expect=8e-24]} {Smed: dd_Smed_v6_3628_0_1, dd_Smed_v6_3628_0_1, [RH, Score=123, Expect=2e-30]} {RNA1509_34970} {RNA1310_2885} {RNA815_12050} |
20. | MligTC455_15016 | 70 | 1.45 | Mlig455_030543 | Neo: - Age: - |
LHX3 | 2.533 | 0.830 | - | 0.750 | - | 0.953 | - | Mlig455_030543 {REF} {Length: 2024} {Pfam: LIM domain [PF00412.24, score=113.8]; Homeodomain [PF00046.31, score=69.9]; Homeobox KN domain [PF05920.13, score=20.4]} {Human: ENSG00000107187, LHX3, LIM homeobox 3, [RH, Score=319, Expect=6e-106]; ENSG00000121454, LHX4, LIM homeobox 4, [RH, Score=311, Expect=1e-102]} {Mouse: ENSMUSG00000026934, Lhx3, LIM homeobox protein 3, [RH, Score=319, Expect=8e-106]; ENSMUSG00000026468, Lhx4, LIM homeobox protein 4, [RH, Score=311, Expect=6e-103]} {Dmel: FBgn0002023, Lim3, [RH, Score=323, Expect=5e-106]} {Celegans: WBGene00000438, ceh-14, Homeobox protein ceh-14, [RH, Score=267, Expect=2e-86]} {Smed: dd_Smed_v6_20755_0_1, dd_Smed_v6_20755_0_1, [RH, Score=328, Expect=3e-111]} {RNA1310_33977} {RNA815_27636} |
21. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 2.519 | 0.783 | - | 0.951 | - | 0.785 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
22. | MligTC455_19887 | 43 | 0.9 | Mlig455_012639, Mlig455_012658 | Neo: - Age: - |
AC243734.1 | 2.499 | 0.715 | - | 0.957 | - | 0.827 | - | Mlig455_012639 {REF} {Length: 2609} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=222.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=213.5]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=270, Expect=7e-83]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=267, Expect=1e-81]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=271, Expect=2e-83]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=426, Expect=7e-143]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=317, Expect=8e-101]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=311, Expect=7e-99]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} Mlig455_012658 {REF} {Length: 2365} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=183.1]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=164.1]} {Human: ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=2e-115]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=350, Expect=4e-116]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=360, Expect=2e-119]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=409, Expect=5e-138]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=335, Expect=5e-110]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=400, Expect=3e-135]} {RNA1509_48029} {RNA1310_34222.1} {RNA815_33884} |
23. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
2.479 | - | 0.703 | 0.788 | - | 0.988 | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
24. | MligTC455_47544 | 42 | 0.88 | Mlig455_055595, Mlig455_055624 | Neo: - Age: - |
RASL10B | 2.419 | 0.702 | 0.763 | - | - | 0.954 | - | Mlig455_055595 {REF} {Length: 1887} {Pfam: Ras family [PF00071.24, score=75.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=34.0]; AAA ATPase domain [PF13191.8, score=20.2]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=151, Expect=2e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=151, Expect=2e-44]} {Dmel: FBgn0037326, CG14669, [Score=112, Expect=1e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=54.7, Expect=7e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} Mlig455_055624 {REF} {Length: 1840} {Pfam: Ras family [PF00071.24, score=74.4]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=33.3]; AAA ATPase domain [PF13191.8, score=19.8]} {Human: ENSG00000270885, RASL10B, RAS like family 10 member B, [Score=150, Expect=4e-44]} {Mouse: ENSMUSG00000020684, Rasl10b, RAS-like, family 10, member B, [Score=152, Expect=6e-45]} {Dmel: FBgn0037326, CG14669, [Score=111, Expect=2e-28]} {Celegans: WBGene00004307, rap-1, Ras-related protein Rap-1, [Score=56.2, Expect=2e-09]} {Smed: dd_Smed_v6_13540_0_1, dd_Smed_v6_13540_0_1, [Score=186, Expect=3e-57]} {RNA1310_59421} {RNA815_58204} |
25. | MligTC455_34369 | 112 | 2.34 | Mlig455_015308, Mlig455_015354, Mlig455_036248, Mlig455_068737, Mlig455_070110 | Neo: - Age: Up-Down-Up Region-enriched R2: 5.462/0.00546 |
2.399 | 0.733 | - | 0.955 | - | 0.711 | - | Mlig455_015308 {REF} {Length: 1459} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.9]} {RNA1310_34740} {RNA815_15663} Mlig455_015354 {REF} {Length: 1446} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=66.3]; Sialidase, N-terminal domain [PF02973.18, score=18.5]} {RNA1310_34740} {RNA815_15663} Mlig455_036248 {REF} {Length: 2111} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=120.9]; Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=28.5]; PAN domain [PF00024.28, score=19.9]} {RNA1509_45496} {RNA1310_2539.1} {RNA815_252.1} Mlig455_068737 {REF} {Length: 1096} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.3]; Sialidase, N-terminal domain [PF02973.18, score=19.9]} {RNA1310_34740} {RNA815_37905} Mlig455_070110 {REF} {Length: 1340} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=109.6]} {RNA1509_32599} {RNA1310_1659} {RNA815_252.1} |
|
26. | MligTC455_51759 | 40 | 0.83 | Mlig455_026782 | Neo: - Age: - Region-enriched R4: 4.435/0.02831 |
CNBD2 | 1.938 | - | - | 0.986 | - | 0.952 | - | Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620} |
27. | MligTC455_29587 | 14 | 0.29 | Mlig455_044070 | Neo: - Age: - |
1.921 | - | - | 0.936 | - | 0.985 | - | Mlig455_044070 {REF} {Length: 1365} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} | |
28. | MligTC455_13433 | 11 | 0.22 | Mlig455_025860 | Neo: - Age: - Region-enriched R2: 6.296/0.01497 |
1.911 | - | - | 0.942 | - | 0.969 | - | Mlig455_025860 {REF} {Length: 1640} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=35.7]} {RNA1310_51631} {RNA815_34338} | |
29. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 1.911 | - | - | 0.950 | - | 0.961 | - | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
30. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.905 | - | - | 0.952 | - | 0.953 | - | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
31. | MligTC455_49492 | 10 | 0.21 | Mlig455_054890 | Neo: - Age: - |
1.898 | - | - | 0.958 | - | 0.940 | - | Mlig455_054890 {REF} {Length: 1524} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
32. | MligTC455_10017 | 8 | 0.17 | Mlig455_034677 | Neo: - Age: - |
GUCY2F | 1.896 | - | - | 0.954 | - | 0.942 | - | Mlig455_034677 {REF} {Length: 4582} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.9]; Protein kinase domain [PF00069.27, score=72.7]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=633, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=641, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=708, Expect=0.0]} {RNA1310_64185} |
33. | MligTC455_49212 | 27 | 0.56 | Mlig455_062516 | Neo: - Age: - |
1.896 | - | - | 0.963 | 0.933 | - | - | Mlig455_062516 {REF} {Length: 1241} {RNA1310_27155} {RNA815_39321} | |
34. | MligTC455_37188 | 31 | 0.65 | Mlig455_000345 | Neo: - Age: - |
TRAF5 | 1.895 | - | - | 0.976 | - | 0.919 | - | Mlig455_000345 {REF} {Length: 892} {Human: ENSG00000082512, TRAF5, TNF receptor associated factor 5, [Score=67.8, Expect=2e-12]; ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=65.5, Expect=8e-12]} {Mouse: ENSMUSG00000111385, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]; ENSMUSG00000026637, Traf5, TNF receptor-associated factor 5, [Score=75.1, Expect=8e-16]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=65.1, Expect=6e-12]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [Score=92.0, Expect=3e-21]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [Score=108, Expect=5e-27]} |
35. | MligTC455_11064 | 54 | 1.12 | Mlig455_004434, Mlig455_004446 | Neo: - Age: - |
1.894 | - | - | 0.927 | - | 0.967 | - | Mlig455_004434 {REF} {Length: 532} {TRANSSPLICED} {RNA1310_102702} Mlig455_004446 {REF} {Length: 617} {TRANSSPLICED} {RNA1310_102702} |
|
36. | MligTC455_10018 | 16 | 0.32 | Mlig455_034726, Mlig455_067577 | Neo: - Age: - |
GUCY2D, GUCY2F | 1.891 | - | - | 0.950 | - | 0.941 | - | Mlig455_034726 {REF} {Length: 4473} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=210.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=104.6]; Protein kinase domain [PF00069.27, score=72.8]; Receptor family ligand binding region [PF01094.30, score=42.4]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=632, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=640, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=610, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=642, Expect=0.0]} {Celegans: WBGene00001542, gcy-17, Receptor-type guanylate cyclase gcy-17, [RH, Score=452, Expect=2e-140]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [RH, Score=707, Expect=0.0]} {RNA1310_64185} {RNA815_57442} Mlig455_067577 {REF} {Length: 474} {Human: ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=66.2, Expect=9e-13]} {Mouse: ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=65.1, Expect=2e-12]} {Dmel: FBgn0085386, CG34357, [Score=62.0, Expect=1e-11]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [Score=44.7, Expect=9e-06]} {Smed: dd_Smed_v6_39042_0_1, dd_Smed_v6_39042_0_1, [Score=98.2, Expect=2e-25]} {RNA1310_101378} |
37. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.882 | - | - | 0.959 | - | 0.923 | - | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
38. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
1.88 | - | - | 0.927 | - | 0.953 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
39. | MligTC455_49077 | 11 | 0.22 | Mlig455_028465 | Neo: - Age: - |
SCNN1B | 1.88 | - | - | 0.905 | - | 0.975 | - | Mlig455_028465 {REF} {Length: 1973} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.1]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=75.9, Expect=9e-14]} {Mouse: ENSMUSG00000038276, Asic3, acid-sensing (proton-gated) ion channel 3, [Score=65.9, Expect=6e-11]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.8, Expect=7e-10]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=2e-12]} {Smed: dd_Smed_v6_26855_0_1, dd_Smed_v6_26855_0_1, [Score=260, Expect=5e-79]} {RNA1310_116633} |
40. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
1.879 | - | - | 0.915 | - | 0.964 | - | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
41. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
1.877 | - | - | 0.964 | - | 0.913 | - | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
42. | MligTC455_10786 | 15 | 0.32 | Mlig455_018164 | Neo: - Age: - |
1.875 | - | - | 0.917 | - | 0.958 | - | Mlig455_018164 {REF} {Length: 1819} {Pfam: F5/8 type C domain [PF00754.27, score=24.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=57.8, Expect=5e-10]} {RNA1310_114361} | |
43. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 1.874 | - | - | 0.897 | - | 0.977 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
44. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
1.874 | - | - | 0.920 | - | 0.954 | - | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
45. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.864 | - | - | 0.910 | - | 0.954 | - | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
46. | MligTC455_46699 | 33 | 0.69 | Mlig455_037050 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-0.785 Region-enriched R4: 3.253/0.03515 |
1.859 | - | - | 0.902 | - | 0.957 | - | Mlig455_037050 {REF} {Length: 1266} {Pfam: WD repeat binding protein EZH2 [PF11616.10, score=36.8]; NOPS (NUC059) domain [PF08075.13, score=32.2]; YtkA-like [PF13115.8, score=19.1]} {RNA1509_45891} {RNA1310_92759} {RNA815_24028} | |
47. | MligTC455_15212 | 12 | 0.26 | Mlig455_059838 | Neo: - Age: - |
ADRA2A | 1.852 | - | - | 0.954 | - | 0.898 | - | Mlig455_059838 {REF} {Length: 2182} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=239.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=36.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.6]; Olfactory receptor [PF13853.8, score=28.5]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=200, Expect=2e-57]} {Mouse: ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=198, Expect=1e-56]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=185, Expect=5e-51]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=195, Expect=5e-56]} {Smed: dd_Smed_v6_19063_0_1, dd_Smed_v6_19063_0_1, [Score=235, Expect=1e-71]} |
48. | MligTC455_33831 | 198 | 4.13 | Mlig455_029369 | Neo: - Age: - Region-enriched R2: 3.223/0.02852 Regeneration-downregulated TP: -7.340 Regeneration-depleted TP: -7.340 |
GLRA3 | 1.852 | 0.895 | - | 0.957 | - | - | - | Mlig455_029369 {REF} {Length: 3665} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=149.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=84.5]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=257, Expect=5e-80]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=253, Expect=2e-78]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=250, Expect=4e-77]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=251, Expect=2e-77]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=249, Expect=3e-77]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=248, Expect=1e-76]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=243, Expect=1e-74]} {Dmel: FBgn0024963, GluClalpha, [Score=253, Expect=2e-78]} {Celegans: WBGene00000233, avr-15, GluClalpha2B protein, [Score=259, Expect=5e-81]} {Smed: dd_Smed_v6_11342_0_1, dd_Smed_v6_11342_0_1, [RH, Score=480, Expect=2e-167]} {RNA1509_35986} {RNA1310_35528} {RNA815_11925.1} |
49. | MligTC455_48713 | 380 | 7.92 | Mlig455_009259, Mlig455_009268 | Neo: - Age: Down-Up-Down Region-specific R2: 6.962 Region-enriched R2: 4.845/0.00046 |
1.852 | - | - | 0.901 | - | 0.951 | - | Mlig455_009259 {REF} {Length: 654} {RNA1509_35038} {RNA1310_72135} {RNA815_37404} Mlig455_009268 {REF} {Length: 546} {RNA1509_35038} {RNA1310_72135, RNA1509_35038} {RNA1509_35038, RNA815_37404} |
|
50. | MligTC455_53188 | 211 | 4.39 | Mlig455_029600 | Neo: - Age: Down-Up-Up |
1.851 | 0.900 | - | - | - | 0.951 | - | Mlig455_029600 {REF} {Length: 1979} {Pfam: Globin [PF00042.24, score=38.2]} {RNA1509_38771} {RNA1310_34513} {RNA815_16338} | |
51. | MligTC455_31663 | 23 | 0.48 | Mlig455_013845 | Neo: - Age: - |
1.849 | - | - | 0.962 | - | 0.887 | - | Mlig455_013845 {REF} {Length: 1056} {RNA1310_32319} {RNA815_18072} | |
52. | MligTC455_37701 | 47 | 0.98 | Mlig455_029831 | Neo: - Age: - Region-enriched R2: 8.298/0.02665 |
1.839 | - | - | 0.872 | - | 0.967 | - | Mlig455_029831 {REF} {Length: 724} {RNA1310_73844} | |
53. | MligTC455_35769 | 90 | 1.87 | Mlig455_034140, Mlig455_050376, Mlig455_062180 | Neo: - |
1.837 | - | - | 0.964 | - | 0.873 | - | Mlig455_034140 {REF} {Length: 1714} {RNA1509_25690} {RNA1310_57234} {RNA815_17883} Mlig455_050376 {REF} {Length: 2093} {TRANSSPLICED} {RNA1509_54944} {RNA1310_23258} {RNA815_47172} Mlig455_062180 {REF} {Length: 90} {NoTransDecoderORF} {RNA1509_25690} {RNA1310_65891} {RNA815_17883} |
|
54. | MligTC455_29085 | 34 | 0.72 | Mlig455_047082 | Neo: - Age: - |
RASGRF2 | 1.826 | - | - | 0.959 | 0.867 | - | - | Mlig455_047082 {REF} {Length: 6322} {Pfam: RasGEF domain [PF00617.21, score=194.4]; RhoGEF domain [PF00621.22, score=120.6]; RasGEF N-terminal motif [PF00618.22, score=68.8]; PH domain [PF00169.31, score=20.4]} {Human: ENSG00000113319, RASGRF2, Ras protein specific guanine nucleotide releasing factor 2, [Score=570, Expect=0.0]; ENSG00000058335, RASGRF1, Ras protein specific guanine nucleotide releasing factor 1, [Score=566, Expect=3e-178]} {Mouse: ENSMUSG00000032356, Rasgrf1, RAS protein-specific guanine nucleotide-releasing factor 1, [Score=565, Expect=5e-178]} {Dmel: FBgn0001965, Sos, Son of sevenless, [Score=167, Expect=4e-41]} {Celegans: WBGene00004947, sos-1, Son of sevenless homolog, [Score=119, Expect=1e-26]} {Smed: dd_Smed_v6_18313_0_2, dd_Smed_v6_18313_0_2, [Score=815, Expect=0.0]} {RNA1509_15697, RNA1509_53969} {RNA1310_2543.1, RNA1509_53969} {RNA1509_53969, RNA815_8228.1} |
55. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.825 | - | - | 0.868 | - | 0.957 | - | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
56. | MligTC455_32326 | 37 | 0.77 | Mlig455_001525 | Neo: - Age: - |
TRIM9 | 1.823 | - | - | 0.959 | - | 0.864 | - | Mlig455_001525 {REF} {Length: 3229} {Pfam: SPRY domain [PF00622.30, score=48.4]; B-box zinc finger [PF00643.26, score=33.5]; zinc finger of C3HC4-type, RING [PF15227.8, score=28.5]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=28.1]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=25.4]; RING-type zinc-finger [PF13445.8, score=24.0]; Fibronectin type III domain [PF00041.23, score=23.3]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=21.4]; Prokaryotic RING finger family 4 [PF14447.8, score=18.8]} {Human: ENSG00000100505, TRIM9, tripartite motif containing 9, [Score=475, Expect=2e-158]} {Mouse: ENSMUSG00000021071, Trim9, tripartite motif-containing 9, [Score=474, Expect=3e-158]} {Dmel: FBgn0051721, Trim9, Tripartite motif containing 9, [Score=444, Expect=1e-146]} {Celegans: WBGene00016539, madd-2, [Score=409, Expect=1e-132]} {Smed: dd_Smed_v6_8386_0_1, dd_Smed_v6_8386_0_1, [Score=524, Expect=1e-177]} {RNA1509_37451} {RNA1310_8634.1} {RNA815_9833} |
57. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 1.822 | - | - | 0.950 | - | 0.872 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
58. | MligTC455_19912 | 180 | 3.75 | Mlig455_035062, Mlig455_035081 | Neo: - Age: - Region-enriched R2: 3.574/0.00043 Regeneration-upregulated R6: 3.449 Regeneration-enriched R6: 3.449 |
SOX2 | 1.812 | 0.860 | - | 0.952 | - | - | - | Mlig455_035062 {REF} {Length: 2855} {Pfam: HMG (high mobility group) box [PF00505.21, score=93.6]; HMG-box domain [PF09011.12, score=43.3]; SOX transcription factor [PF12336.10, score=31.1]} {Human: ENSG00000181449, SOX2, SRY-box 2, [Score=182, Expect=7e-53]} {Mouse: ENSMUSG00000074637, Sox2, SRY (sex determining region Y)-box 2, [RH, Score=182, Expect=3e-53]} {Dmel: FBgn0029123, SoxN, SoxNeuro, [RH, Score=168, Expect=6e-45]} {Celegans: WBGene00004949, sox-2, Transcription factor sox-2, [RH, Score=174, Expect=1e-50]} {Smed: dd_Smed_v6_13215_0_1, dd_Smed_v6_13215_0_1, [RH, Score=161, Expect=2e-43]} {RNA1509_11450} {RNA1310_17800.1} {RNA815_36848} Mlig455_035081 {REF} {Length: 2804} {Pfam: HMG (high mobility group) box [PF00505.21, score=93.8]; HMG-box domain [PF09011.12, score=41.9]; SOX transcription factor [PF12336.10, score=30.8]} {Human: ENSG00000181449, SOX2, SRY-box 2, [Score=182, Expect=5e-53]} {Mouse: ENSMUSG00000074637, Sox2, SRY (sex determining region Y)-box 2, [RH, Score=183, Expect=3e-53]} {Dmel: FBgn0029123, SoxN, SoxNeuro, [RH, Score=171, Expect=1e-45]} {Celegans: WBGene00004949, sox-2, Transcription factor sox-2, [RH, Score=174, Expect=9e-51]} {Smed: dd_Smed_v6_13215_0_1, dd_Smed_v6_13215_0_1, [RH, Score=161, Expect=2e-43]} {RNA1509_11450} {RNA1310_17800.1} {RNA815_36848} |
59. | MligTC455_12126 | 26 | 0.55 | Mlig455_040946 | Neo: - Age: - |
1.807 | - | - | 0.834 | - | 0.973 | - | Mlig455_040946 {REF} {Length: 1894} {RNA1310_146540} {RNA815_59956} | |
60. | MligTC455_40075 | 72 | 1.5 | Mlig455_003636, Mlig455_003841 | Neo: - Age: - |
1.804 | - | - | 0.826 | - | 0.978 | - | Mlig455_003636 {REF} {Length: 1017} {Pfam: PAN domain [PF00024.28, score=20.3]} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=69.7, Expect=2e-14]} {RNA1310_45613} {RNA815_17816.1} Mlig455_003841 {REF} {Length: 978} {TRANSSPLICED} {Smed: dd_Smed_v6_38541_0_1, dd_Smed_v6_38541_0_1, [RH, Score=70.5, Expect=1e-14]} {RNA1310_45613} {RNA815_17816.1} |
|
61. | MligTC455_23006 | 48 | 1 | Mlig455_001776 | Neo: - Age: logFC(26M/2M)=-0.676 |
1.803 | - | - | 0.816 | - | 0.987 | - | Mlig455_001776 {REF} {Length: 2604} {RNA1310_41105} {RNA815_50956} | |
62. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
1.797 | - | - | 0.968 | - | 0.829 | - | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
63. | MligTC455_40617 | 11 | 0.22 | Mlig455_043552 | Neo: - Age: - |
WSCD2 | 1.788 | - | - | 0.828 | - | 0.960 | - | Mlig455_043552 {REF} {Length: 962} {Pfam: WSC domain [PF01822.21, score=54.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=57.8, Expect=3e-09]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=58.2, Expect=1e-09]} |
64. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 1.786 | 0.827 | - | 0.959 | - | - | - | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
65. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
1.786 | - | - | 0.972 | 0.814 | - | - | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
66. | MligTC455_21967 | 46 | 0.96 | Mlig455_059500 | Neo: - Age: logFC(26M/2M)=-0.481 |
1.78 | 0.799 | - | - | - | 0.981 | - | Mlig455_059500 {REF} {Length: 3977} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=186.4]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=53.5, Expect=6e-07]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=382, Expect=8e-125]} {RNA1509_57431} {RNA1310_11500} {RNA815_5893} | |
67. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 1.778 | - | 0.820 | 0.958 | - | - | - | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
68. | MligTC455_52570 | 71 | 1.49 | Mlig455_066071 | Neo: - Age: Up-Down-Up |
1.775 | - | - | 0.954 | - | 0.821 | - | Mlig455_066071 {REF} {Length: 2575} {Pfam: Hemingway/CFA97 [PF13879.8, score=54.6]; Annexin [PF00191.22, score=26.1]} {Mouse: ENSMUSG00000090336, Cfap97d2, CFAP97 domain containing 2, [Score=46.6, Expect=3e-06]} {Smed: dd_Smed_v6_2676_0_1, dd_Smed_v6_2676_0_1, [Score=70.1, Expect=2e-13]} {RNA1310_29320.1} {RNA815_54680} | |
69. | MligTC455_13974 | 47 | 0.99 | Mlig455_057616 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.685/0.01506 |
OTOP2 | 1.772 | - | - | 0.974 | - | 0.798 | - | Mlig455_057616 {REF} {Length: 8915} {Pfam: Otopetrin [PF03189.15, score=235.3]} {Human: ENSG00000183034, OTOP2, otopetrin 2, [Score=56.2, Expect=1e-07]} {Mouse: ENSMUSG00000050201, Otop2, otopetrin 2, [Score=60.5, Expect=4e-09]} {Dmel: FBgn0259150, CG42265, [Score=196, Expect=3e-52]} {Celegans: WBGene00010403, otpl-8, OToPetrin-Like, [Score=114, Expect=3e-26]} {Smed: dd_Smed_v6_13612_0_4, dd_Smed_v6_13612_0_4, [Score=295, Expect=4e-91]} {RNA1509_7353} {RNA1310_933} {RNA815_252.1} |
70. | MligTC455_14057 | 47 | 0.97 | Mlig455_050243 | Neo: - Age: - |
GRIK1 | 1.772 | - | - | - | 0.799 | 0.973 | - | Mlig455_050243 {REF} {Length: 3866} {Pfam: Ligand-gated ion channel [PF00060.28, score=173.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=119.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=62.8]; Receptor family ligand binding region [PF01094.30, score=53.1]; Unstructured region C-term to UIM in Ataxin3 [PF16619.7, score=18.7]} {Human: ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=579, Expect=0.0]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=571, Expect=0.0]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=558, Expect=0.0]} {Mouse: ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=580, Expect=0.0]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=570, Expect=0.0]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=559, Expect=0.0]} {Dmel: FBgn0038837, CG3822, [Score=528, Expect=9e-173]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=422, Expect=6e-133]} {Smed: dd_Smed_v6_8816_0_1, dd_Smed_v6_8816_0_1, [Score=605, Expect=0.0]} {RNA1509_25923} {RNA1310_74435} {RNA815_4408.2} |
71. | MligTC455_17932 | 22 | 0.45 | Mlig455_002921, Mlig455_002939 | Neo: - Age: - |
KCP | 1.769 | - | - | 0.952 | 0.817 | - | - | Mlig455_002921 {REF} {Length: 969} {Pfam: von Willebrand factor type C domain [PF00093.20, score=44.3]; EGF domain [PF12947.9, score=28.3]; MSP1 EGF domain 1 [PF12946.9, score=18.9]} {Human: ENSG00000135253, KCP, kielin/chordin-like protein, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=58.5, Expect=1e-08]} {Celegans: WBGene00008952, F19C6.3, [Score=51.2, Expect=1e-06]} {Smed: dd_Smed_v6_11653_0_1, dd_Smed_v6_11653_0_1, [Score=58.5, Expect=5e-09]} {RNA1310_81278} Mlig455_002939 {REF} {Length: 884} {Pfam: von Willebrand factor type C domain [PF00093.20, score=44.7]; EGF domain [PF12947.9, score=28.9]; MSP1 EGF domain 1 [PF12946.9, score=20.4]} {Human: ENSG00000135253, KCP, kielin/chordin-like protein, [Score=55.5, Expect=1e-07]} {Mouse: ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=57.8, Expect=2e-08]} {Celegans: WBGene00008952, F19C6.3, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_11653_0_1, dd_Smed_v6_11653_0_1, [Score=51.6, Expect=5e-07]} {RNA1310_81278} |
72. | MligTC455_13006 | 55 | 1.15 | Mlig455_044901 | Neo: - Age: - |
PCDH11Y | 1.768 | - | - | 0.954 | - | 0.814 | - | Mlig455_044901 {REF} {Length: 6092} {Pfam: Cadherin domain [PF00028.19, score=276.7]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=79.8]; Cadherin-like [PF08266.14, score=44.2]; Cadherin-like [PF16184.7, score=39.5]; Cadherin prodomain like [PF08758.13, score=30.3]} {Human: ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=292, Expect=5e-80]; ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=291, Expect=5e-80]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [Score=281, Expect=9e-78]} {Dmel: FBgn0001075, ft, fat, [Score=239, Expect=3e-63]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=206, Expect=3e-53]} {Smed: dd_Smed_v6_18373_0_1, dd_Smed_v6_18373_0_1, [Score=290, Expect=1e-80]} {RNA1509_54067} {RNA1310_21501} {RNA815_32416} |
73. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
1.766 | - | - | 0.797 | - | 0.969 | - | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
74. | MligTC455_15881 | 222 | 4.62 | Mlig455_053354, Mlig455_053359 | Neo: - Age: - |
DCLK3 | 1.764 | - | - | 0.961 | - | 0.803 | - | Mlig455_053354 {REF} {Length: 5391} {Pfam: Protein kinase domain [PF00069.27, score=245.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.8]; Doublecortin [PF03607.19, score=83.2]} {Human: ENSG00000163673, DCLK3, doublecortin like kinase 3, [RH, Score=350, Expect=8e-109]; ENSG00000133083, DCLK1, doublecortin like kinase 1, [RH, Score=347, Expect=4e-110]; ENSG00000170390, DCLK2, doublecortin like kinase 2, [RH, Score=343, Expect=4e-105]} {Mouse: ENSMUSG00000032500, Dclk3, doublecortin-like kinase 3, [RH, Score=348, Expect=3e-106]; ENSMUSG00000027797, Dclk1, doublecortin-like kinase 1, [RH, Score=347, Expect=2e-106]; ENSMUSG00000028078, Dclk2, doublecortin-like kinase 2, [RH, Score=342, Expect=5e-105]} {Dmel: FBgn0261387, CG17528, [RH, Score=297, Expect=4e-88]} {Celegans: WBGene00000553, cmk-1, Calcium/calmodulin-dependent protein kinase type 1, [Score=258, Expect=3e-78]} {Smed: dd_Smed_v6_12689_0_1, dd_Smed_v6_12689_0_1, [RH, Score=347, Expect=6e-105]} {RNA1509_51067} {RNA1310_13514} {RNA815_32297} Mlig455_053359 {REF} {Length: 4205} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=245.7]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=117.8]; Doublecortin [PF03607.19, score=83.2]} {Human: ENSG00000163673, DCLK3, doublecortin like kinase 3, [RH, Score=350, Expect=8e-109]; ENSG00000133083, DCLK1, doublecortin like kinase 1, [RH, Score=347, Expect=4e-110]; ENSG00000170390, DCLK2, doublecortin like kinase 2, [RH, Score=343, Expect=4e-105]} {Mouse: ENSMUSG00000032500, Dclk3, doublecortin-like kinase 3, [RH, Score=348, Expect=3e-106]; ENSMUSG00000027797, Dclk1, doublecortin-like kinase 1, [RH, Score=347, Expect=2e-106]; ENSMUSG00000028078, Dclk2, doublecortin-like kinase 2, [RH, Score=342, Expect=5e-105]} {Dmel: FBgn0261387, CG17528, [RH, Score=297, Expect=4e-88]} {Celegans: WBGene00000553, cmk-1, Calcium/calmodulin-dependent protein kinase type 1, [Score=258, Expect=3e-78]} {Smed: dd_Smed_v6_12689_0_1, dd_Smed_v6_12689_0_1, [RH, Score=347, Expect=6e-105]} {RNA1509_51067} {RNA1310_13514, RNA1509_51067} {RNA1509_51067, RNA815_32297} |
75. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
1.76 | - | - | 0.957 | - | 0.803 | - | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
76. | MligTC455_52814 | 47 | 0.97 | Mlig455_047356, Mlig455_047365 | Neo: - Age: - |
CNTN2 | 1.76 | - | - | 0.791 | - | 0.969 | - | Mlig455_047356 {REF} {Length: 2537} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.8]; Immunoglobulin domain [PF13927.8, score=52.6]; Immunoglobulin domain [PF13895.8, score=40.4]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=25.9]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=58.5, Expect=3e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=56.6, Expect=8e-08]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=55.1, Expect=2e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=54.7, Expect=3e-07]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=58.2, Expect=2e-08]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=2e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_18728} Mlig455_047365 {REF} {Length: 3489} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=57.9]; Immunoglobulin domain [PF13927.8, score=52.8]; Immunoglobulin domain [PF13895.8, score=40.5]; Immunoglobulin domain [PF00047.27, score=40.3]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=26.4]} {Human: ENSG00000184144, CNTN2, contactin 2, [Score=57.4, Expect=5e-08]} {Mouse: ENSMUSG00000053024, Cntn2, contactin 2, [Score=55.5, Expect=1e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=53.9, Expect=5e-07]; ENSMUSG00000061751, Kalrn, kalirin, RhoGEF kinase, [Score=53.5, Expect=6e-07]; ENSMUSG00000055022, Cntn1, contactin 1, [Score=52.8, Expect=1e-06]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=1e-06]} {Dmel: FBgn0264975, Nrg, Neuroglian, [Score=55.5, Expect=1e-07]} {Smed: dd_Smed_v6_15129_0_1, dd_Smed_v6_15129_0_1, [RH, Score=99.8, Expect=1e-22]} {RNA1509_60115} {RNA1310_31768} {RNA815_19521} |
77. | MligTC455_15771 | 15 | 0.31 | Mlig455_013616 | Neo: - Age: - |
1.753 | - | - | 0.798 | - | 0.955 | - | Mlig455_013616 {REF} {Length: 1678} {Pfam: Glycine rich protein [PF12810.9, score=28.8]} {RNA1509_48637} {RNA1310_55197} {RNA815_27869} | |
78. | MligTC455_53295 | 119 | 2.48 | Mlig455_060263 | Neo: - Age: - |
LMO4 | 1.753 | 0.781 | - | 0.972 | - | - | - | Mlig455_060263 {REF} {Length: 1717} {Pfam: LIM domain [PF00412.24, score=87.3]} {Human: ENSG00000143013, LMO4, LIM domain only 4, [Score=133, Expect=9e-39]} {Mouse: ENSMUSG00000028266, Lmo4, LIM domain only 4, [Score=133, Expect=6e-39]} {Dmel: FBgn0032196, CG5708, [Score=120, Expect=4e-33]} {Celegans: WBGene00002987, lim-4, LIM domain family; Putative transcription factor LIM-4, [Score=75.5, Expect=9e-16]} {Smed: dd_Smed_v6_27625_0_1, dd_Smed_v6_27625_0_1, [RH, Score=108, Expect=1e-28]} {RNA1509_53632} {RNA1310_25695, RNA1509_53632} {RNA1509_53632, RNA815_42113} |
79. | MligTC455_24406 | 204 | 4.25 | Mlig455_043947 | Neo: - Age: - Region-specific R2: 3.852 Region-enriched R2: 3.953/0.00003 |
1.752 | - | - | 0.962 | - | 0.790 | - | Mlig455_043947 {REF} {Length: 1609} {RNA1509_54091} {RNA1310_68348.1, RNA1509_54091} {RNA1509_54091, RNA815_33570.1} | |
80. | MligTC455_53305 | 76 | 1.58 | Mlig455_039152 | Neo: - Age: logFC(26M/2M)=-0.689 |
1.752 | - | - | - | 0.787 | 0.965 | - | Mlig455_039152 {REF} {Length: 1863} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=49.3, Expect=2e-06]} {RNA1509_24214} {RNA1310_21641} {RNA815_11396} | |
81. | MligTC455_23287 | 106 | 2.21 | Mlig455_052789 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.273/0.00029 |
1.751 | - | 0.799 | 0.952 | - | - | - | Mlig455_052789 {REF} {Length: 2348} {RNA1310_41474} {RNA815_41242} | |
82. | MligTC455_47590 | 22 | 0.46 | Mlig455_017675, Mlig455_053765 | Neo: - Age: - |
LRRC74A | 1.75 | - | - | - | 0.777 | 0.973 | - | Mlig455_017675 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} Mlig455_053765 {REF} {Length: 3797} {Pfam: Leucine Rich repeat [PF13516.8, score=47.9]; EF-hand domain pair [PF13499.8, score=29.1]; EF-hand domain [PF13405.8, score=28.8]; EF hand [PF00036.34, score=28.6]; EF-hand domain pair [PF13833.8, score=18.6]} {Human: ENSG00000100565, LRRC74A, leucine rich repeat containing 74A, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000059114, Lrrc74a, leucine rich repeat containing 74A, [Score=142, Expect=5e-36]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [Score=50.4, Expect=5e-07]} {Smed: dd_Smed_v6_14506_0_1, dd_Smed_v6_14506_0_1, [Score=169, Expect=4e-45]} {RNA1310_50089} |
83. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
1.748 | 0.784 | - | 0.964 | - | - | - | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
84. | MligTC455_16236 | 30 | 0.62 | Mlig455_010759 | Neo: - Age: - |
HRH1 | 1.739 | - | - | 0.779 | - | 0.960 | - | Mlig455_010759 {REF} {Length: 2245} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=249.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=58.5]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.8]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=20.4]; Protein of unknown function (DUF4022) [PF13214.8, score=19.6]} {Human: ENSG00000196639, HRH1, histamine receptor H1, [Score=179, Expect=3e-49]; ENSG00000149295, DRD2, dopamine receptor D2, [Score=172, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=172, Expect=3e-47]; ENSMUSG00000053004, Hrh1, histamine receptor H1, [Score=171, Expect=3e-46]; ENSMUSG00000046159, Chrm3, cholinergic receptor, muscarinic 3, cardiac, [Score=166, Expect=1e-43]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=252, Expect=4e-73]} {Celegans: WBGene00001053, dop-2, D2-like dopamine receptor long variant; DOPamine receptor, [RH, Score=173, Expect=6e-46]} {Smed: dd_Smed_v6_34803_0_1, dd_Smed_v6_34803_0_1, [RH, Score=241, Expect=1e-75]} {RNA1509_32954} {RNA1310_36460} {RNA815_785} |
85. | MligTC455_44922 | 15 | 0.31 | Mlig455_040611 | Neo: - Age: - |
AC254952.1 | 1.738 | - | - | 0.959 | 0.779 | - | - | Mlig455_040611 {REF} {Length: 1658} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=86.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=85.3]} {Human: ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=1e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=152, Expect=2e-40]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=147, Expect=9e-39]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=129, Expect=1e-32]} {Celegans: WBGene00001133, eat-2, Neuronal acetylcholine receptor subunit eat-2, [Score=136, Expect=2e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=136, Expect=2e-35]} {RNA1310_45581} {RNA815_21574} |
86. | MligTC455_16749 | 454 | 9.45 | Mlig455_001550, Mlig455_046548 | Neo: - Age: logFC(26M/2M)=0.515 Region-specific R2: 4.360 Region-enriched R2: 3.409/0.00015 |
TRAF4 | 1.737 | 0.783 | - | 0.954 | - | - | - | Mlig455_001550 {REF} {Length: 4563} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=237, Expect=4e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=241, Expect=7e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=1e-44]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=276, Expect=1e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813, RNA1509_20900} {RNA1509_20900, RNA815_2335.1} Mlig455_046548 {REF} {Length: 3881} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=236, Expect=1e-71]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=240, Expect=3e-73]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=9e-45]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=275, Expect=6e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813} {RNA815_2335.1} |
87. | MligTC455_13942 | 192 | 4 | Mlig455_015587 | Neo: - |
SYT14 | 1.727 | 0.772 | - | - | 0.955 | - | - | Mlig455_015587 {REF} {Length: 3362} {Pfam: C2 domain [PF00168.32, score=38.6]} {Human: ENSG00000143469, SYT14, synaptotagmin 14, [Score=133, Expect=5e-32]; ENSG00000139973, SYT16, synaptotagmin 16, [Score=129, Expect=2e-30]} {Mouse: ENSMUSG00000016200, Syt14, synaptotagmin XIV, [Score=134, Expect=8e-32]} {Dmel: FBgn0261086, Syt14, Synaptotagmin 14, [Score=108, Expect=3e-24]} {Smed: dd_Smed_v6_9548_0_2, dd_Smed_v6_9548_0_2, [Score=136, Expect=2e-34]} {RNA1509_12596} {RNA1310_670.1, RNA1509_12596} {RNA1509_12596, RNA815_7240.1} |
88. | MligTC455_10439 | 11 | 0.23 | Mlig455_000558, Mlig455_030354 | Neo: - Age: - |
FGG | 1.722 | - | 0.772 | 0.950 | - | - | - | Mlig455_000558 {REF} {Length: 2277} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=55.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=107, Expect=5e-24]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=100, Expect=3e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-19]} {Celegans: WBGene00012782, Y43C5A.2, [RH, Score=54.3, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.8, Expect=3e-13]} {RNA1310_33683.1} {RNA815_41841} Mlig455_030354 {REF} {Length: 2960} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=118.9]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=104, Expect=3e-23]} {Mouse: ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.6, Expect=2e-21]; ENSMUSG00000039899, Fgl2, fibrinogen-like protein 2, [Score=95.5, Expect=2e-20]; ENSMUSG00000026835, Fcnb, ficolin B, [Score=94.4, Expect=1e-20]} {Dmel: FBgn0051832, CG31832, [Score=89.4, Expect=8e-20]} {Celegans: WBGene00012782, Y43C5A.2, [Score=48.9, Expect=9e-06]} {Smed: dd_Smed_v6_21509_0_1, dd_Smed_v6_21509_0_1, [Score=80.1, Expect=6e-16]} {RNA1509_41312} {RNA1310_33683.1} {RNA815_41841} |
89. | MligTC455_00899 | 7 | 0.15 | Mlig455_007785 | Neo: - Age: - |
1.718 | - | - | - | - | 0.982 | 0.736 | Mlig455_007785 {REF} {Length: 337} {NoTransDecoderORF} | |
90. | MligTC455_35000 | 20 | 0.42 | Mlig455_050562 | Neo: - Age: - |
KCNC1 | 1.718 | - | 0.761 | - | - | 0.957 | - | Mlig455_050562 {REF} {Length: 3042} {Pfam: Ion transport protein [PF00520.33, score=116.8]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=42.0]} {Human: ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=211, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=1e-58]; ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=206, Expect=3e-56]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=204, Expect=3e-57]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=204, Expect=1e-55]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=203, Expect=7e-56]} {Mouse: ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=212, Expect=3e-60]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=209, Expect=2e-57]; ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=206, Expect=2e-56]; ENSMUSG00000027895, Kcnc4, potassium voltage gated channel, Shaw-related subfamily, member 4, [Score=204, Expect=4e-57]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=203, Expect=1e-56]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=203, Expect=4e-56]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=223, Expect=2e-65]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=224, Expect=8e-65]} {Smed: dd_Smed_v6_20858_0_1, dd_Smed_v6_20858_0_1, [RH, Score=567, Expect=0.0]} {RNA1509_22940} {RNA1310_28483} {RNA815_31040} |
91. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
1.716 | - | 0.757 | - | - | 0.959 | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
92. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
1.715 | 0.757 | - | 0.958 | - | - | - | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
93. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
1.712 | - | - | 0.761 | - | 0.951 | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
94. | MligTC455_29543 | 94 | 1.96 | Mlig455_066835 | Neo: - Age: Down-Down-Up Region-enriched R2: 3.991/0.02759 |
PGBD4 | 1.71 | - | - | 0.953 | 0.757 | - | - | Mlig455_066835 {REF} {Length: 7088} {Pfam: Transposase IS4 [PF13843.8, score=213.7]} {Human: ENSG00000182405, PGBD4, piggyBac transposable element derived 4, [RH, Score=206, Expect=4e-59]} {Mouse: ENSMUSG00000050751, Pgbd5, piggyBac transposable element derived 5, [RH, Score=74.3, Expect=1e-13]} {Dmel: FBgn0037633, CG9839, [RH, Score=96.3, Expect=7e-21]} {Smed: dd_Smed_v6_48522_0_1, dd_Smed_v6_48522_0_1, [RH, Score=116, Expect=1e-29]} {RNA1509_18157} {RNA1310_616.1} {RNA815_9301.1} |
95. | MligTC455_33704 | 135 | 2.81 | Mlig455_002733 | Neo: - Age: Up-Down-Down |
COL5A2 | 1.709 | 0.753 | - | 0.956 | - | - | - | Mlig455_002733 {REF} {Length: 6615} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=136.4]; Myotubularin protein [PF12335.10, score=23.9]} {Human: ENSG00000204262, COL5A2, collagen type V alpha 2 chain, [Score=113, Expect=6e-25]; ENSG00000049089, COL9A2, collagen type IX alpha 2 chain, [Score=111, Expect=1e-24]} {Mouse: ENSMUSG00000026147, Col9a1, collagen, type IX, alpha 1, [Score=124, Expect=2e-28]; ENSMUSG00000026042, Col5a2, collagen, type V, alpha 2, [Score=122, Expect=1e-27]; ENSMUSG00000041984, Rptn, repetin, [Score=121, Expect=1e-27]; ENSMUSG00000045672, Col27a1, collagen, type XXVII, alpha 1, [Score=120, Expect=3e-27]} {Dmel: FBgn0016075, vkg, viking, [Score=106, Expect=5e-23]} {Celegans: WBGene00000708, col-135, COLlagen, [Score=84.0, Expect=2e-16]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=140, Expect=9e-34]} {RNA1310_28728} {RNA815_22052} |
96. | MligTC455_12914 | 32 | 0.66 | Mlig455_026496 | Neo: - Age: - |
ZNF521 | 1.707 | - | - | 0.754 | - | 0.953 | - | Mlig455_026496 {REF} {Length: 3383} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=54.4]; C2H2-type zinc finger [PF13894.8, score=52.8]; Zinc-finger of C2H2 type [PF12874.9, score=31.6]; Zinc-finger double domain [PF13465.8, score=19.7]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=19.2]; C2H2-type zinc finger [PF13912.8, score=18.7]} {Human: ENSG00000198795, ZNF521, zinc finger protein 521, [Score=77.0, Expect=1e-13]} {Mouse: ENSMUSG00000024420, Zfp521, zinc finger protein 521, [Score=75.5, Expect=3e-13]} {Dmel: FBgn0036179, CG7368, [Score=72.4, Expect=1e-12]} {Celegans: WBGene00018567, F47E1.3, [Score=61.6, Expect=2e-09]} {Smed: dd_Smed_v6_7731_0_1, dd_Smed_v6_7731_0_1, [Score=58.5, Expect=1e-09]} {RNA1310_43017} {RNA815_23872} |
97. | MligTC455_50704 | 36 | 0.74 | Mlig455_007321, Mlig455_068329 | Neo: - Age: - |
1.702 | - | - | 0.958 | - | 0.744 | - | Mlig455_007321 {REF} {Length: 1784} {RNA815_63232} Mlig455_068329 {REF} {Length: 1748} {RNA815_63232} |
|
98. | MligTC455_40938 | 28 | 0.57 | Mlig455_002890 | Neo: - |
PRKAR2A | 1.701 | - | - | 0.957 | - | 0.744 | - | Mlig455_002890 {REF} {Length: 3559} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=61.4]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=53.5, Expect=8e-07]; ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=51.2, Expect=4e-06]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=53.1, Expect=8e-07]; ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=51.2, Expect=5e-06]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=154, Expect=2e-39]} {RNA1509_30289} {RNA1310_5962} {RNA815_9809} |
99. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
1.695 | - | 0.735 | - | - | 0.960 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
100. | MligTC455_02868 | 46 | 0.96 | Mlig455_039256 | Neo: - Age: - |
1.692 | - | - | - | 0.713 | 0.979 | - | Mlig455_039256 {REF} {Length: 483} {NoTransDecoderORF} {RNA1310_63888} {RNA815_2549.2} |